Last updated on September 2017

Effect of Hepatic and Renal Impairment on the Pharmacokinetics Safety and Tolerability of BAY1841788 (ODM-201)


Brief description of study

Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).

Clinical Study Identifier: NCT02894385

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations